- Oral presentation
- Open Access
High prevalence of cytomegalovirus (CMV) infection in infants born to HIV infected mothers–ANRS French Perinatal Cohort (EPF)
© Guibert et al.; licensee BioMed Central Ltd. 2008
- Published: 9 April 2008
- Sensorineural Hearing
- Sensorineural Hearing Loss
- Central Nervous System Disease
- Nervous System Disease
- Infected Mother
In developed countries, 0.3% to 0.5% of all newborns are congenitally infected by cytomegalovirus (CMV) with the risk of sensorineural hearing loss or mental retardation [1, 2]. Few results about congenital CMV infection in infants born to HIV-infected women have been reported . Rate of disease progression and central nervous system disease was found to be higher in HIV-1-infected infants who acquire CMV infection in the first 18 months of life than those infected with HIV-1 alone . We aimed to estimate the prevalence of neonatal CMV infection in children born to HIV-infected mothers between 1993 and 2004 enrolled in the ANRS French Perinatal Cohort (EPF).
EPF is a national prospective multicenter cohort of mother-to-child HIV transmission. As part of the standardized follow-up of infants born alive between 1993 and 2004 in EPF sites, a urine sample was obtained within the ten first days of life. These samples were used to screen for congenital CMV infection, using rapid culture from 1993 to 2001 and real-time PCR since 2001.
Between 1993 and 2004, 4995 of the 7878 newborns included in EPF were screened for CMV. The prevalence of CMV infection was 2.4% (119 positive tests; 95% confidence interval: 2.0–2.8). Thirteen of the 119 CMV infected newborns were also infected with HIV. The prevalence of CMV infection was higher in HIV-infected newborns (10.2%; 95% CI: 4.9-15.5) than in HIV-uninfected newborns (2.2%, 95% CI: 1.8-2.6, p<0.01).
The prevalence of congenital CMV infection was high in children born to HIV- infected mothers and was significantly higher in HIV-infected children than HIV-uninfected children.
The study was supported by the ANRS. We thank all cohort investigators and V Benhammou, N Chernai, A Diop, K Hamrene, P Huynh, C Laurent, M Peres, ERamos, L Boufassa, T Wack, N Zeller.
- Barbi M, Binda S, Caroppo S, Calvario A, Germinario C, Bozzi A, et al: Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J. 2006, 25: 156-159. 10.1097/01.inf.0000199261.98769.29.View ArticlePubMedGoogle Scholar
- Gratacap-Cavallier B, Morand P, Dutertre N, Bosson JL, Baccard-Longere M, Jouk PS, et al: Cytomegalovirus infection in pregnant women. Seroepidemiological prospective study in 1,018 women in Isere. J Gynecol Obstet Biol Reprod (Paris). 1998, 27: 161-166.Google Scholar
- Doyle M, Atkins JT, Rivera-Matos IR: Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1996, 15: 1102-1106. 10.1097/00006454-199612000-00010.View ArticlePubMedGoogle Scholar
- Kovacs A, Schluchter M, Easley K, Demmler G, Shearer W, La Russa P, et al: Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 1999, 341: 77-84. 10.1056/NEJM199907083410203.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.